Watch BHVN. Know when insiders buy.
One email the day a filing lands. Free.
BHVN
Biohaven Ltd.
14.72
−0.97 −6.18%
USD · close Sep 8
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
55
WATCH · shorts 55
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.2BP/E —DIV YIELD —FCF YIELD -23.02%REV TTM —NET INCOME −$586.8MNET CASH —52W 7.79 – 18.11SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$124.9M | −$137.3M | — | -0.91 | −$85.1M | $454K | −$85.6M | Aug 10 |
| Q1 2026 · Mar 31 | — | — | — | −$130.4M | −$130.5M | — | -0.88 | −$149.9M | $0 | −$149.9M | May 4 |
| Q4 2025 · Dec 31derived | — | — | — | −$142.7M | −$145.6M | — | -1.12 | −$130.7M | $8K | −$130.7M | Mar 2 |
| Q3 2025 · Sep 30 | — | — | — | −$169.4M | −$173.4M | — | -1.64 | −$145.7M | $13K | −$145.7M | Nov 10 |
| Q2 2025 · Jun 30 | — | — | — | −$211.7M | −$198.1M | — | -1.94 | −$167.9M | $233K | −$168.2M | Aug 10 |
| Q1 2025 · Mar 31 | — | — | — | −$221.6M | −$221.7M | — | -2.17 | −$165.1M | $461K | −$165.6M | May 4 |
| Q4 2024 · Dec 31derived | — | — | — | −$189.9M | −$186.8M | — | -1.78 | −$170.7M | $49K | −$170.8M | Mar 2 |
| Q3 2024 · Sep 30 | — | — | — | −$178.2M | −$160.3M | — | -1.70 | −$141.3M | $611K | −$141.9M | Nov 10 |
| Q2 2024 · Jun 30 | — | — | — | −$333.8M | −$319.8M | — | -3.64 | −$167.8M | $2.9M | −$170.7M | Aug 11 |
| Q1 2024 · Mar 31 | — | — | — | −$183.2M | −$179.5M | — | -2.20 | −$102.6M | $440K | −$103.1M | May 12 |
| Q4 2023 · Dec 31derived | — | — | — | −$153.7M | −$144.8M | — | -1.87 | −$114.9M | $470K | −$115.4M | Mar 2 |
| Q3 2023 · Sep 30 | — | — | — | −$110.5M | −$102.6M | — | -1.50 | −$94.8M | $1.2M | −$96.1M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$745.4M | −$738.8M | — | -6.86 | −$609.4M | $715K | −$610.2M | — | — |
| FY2024 · to Dec 31 | — | — | −$885.1M | −$846.4M | — | -9.28 | −$582.5M | $4M | −$586.5M | — | — |
| FY2023 · to Dec 31 | — | — | −$436.1M | −$408.2M | — | -5.73 | −$331.7M | $3M | −$334.8M | — | — |
| FY2022 · to Dec 31 | — | — | −$567.9M | −$570.3M | — | -12.75 | −$297.7M | $6.1M | −$303.8M | — | — |
| FY2021 · to Dec 31 | — | — | −$218.9M | −$213.8M | — | -5.43 | −$145.8M | $938K | −$146.8M | — | — |
| FY2020 · to Dec 31 | — | — | −$114.5M | −$118.7M | — | -3.01 | −$76M | $1.1M | −$77.1M | — | — |
Every number comes from Biohaven Ltd.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.